Company Overview - As of August 8, 2025, the stock price of Sely Medical is reported at 27.60 yuan, reflecting an increase of 0.73% from the previous trading day [1] - The company operates in the pharmaceutical commercial sector, focusing on medical testing centralized services and the research, production, and sales of in vitro diagnostic products [1] - Sely Medical's product range includes biochemistry, immunology, and molecular diagnostics, with business operations extending across multiple regions, including Hubei [1] Stock Performance - During the trading session on August 8, Sely Medical's stock exhibited significant volatility, with a morning rebound at 9:35 AM leading to a rise of over 2% within five minutes, followed by a quick pullback at 9:44 AM with a drop exceeding 2% [1] - The stock's opening price was 27.11 yuan, reaching a high of 28.40 yuan and a low of 26.20 yuan, resulting in a trading range of 8.03% [1] - The total trading volume for the day amounted to 9.85 billion yuan [1] Capital Flow - On August 8, the net inflow of main funds was 33.17 million yuan, accounting for 0.63% of the circulating market value [1] - However, over the past five trading days, the overall trend for main funds has shown a net outflow of 456 million yuan, which represents 8.65% of the circulating market value [1]

8月7日，精准医疗概念上涨0.62%，今日主力资金流出9350.36万元，概念股23只上涨，23只下跌。 来源：金融界 主力资金净流出居前的分别为千红制药（1.87亿元）、塞力医疗（1.39亿元）、智飞生物（1.34亿 元）、贝达药业（1.04亿元）、君实生物-U（7825.06万元）。 序号代码名称最新价涨跌幅主力净流入主力净占比1000710贝瑞基因15.625.262.07亿元16.92%2300289利 德曼9.7720.021.58亿元14.9%3002022科华生物7.959.961.43亿元28.2%4002030达安基因7.262.986009.70万 元9.23%5301293三博脑科54.595.125730.70万元6.83%6688289圣湘生物22.210.142969.10万元 12.2%7300676华大基因53.481.02843.77万元4.28%8300244迪安诊断16.070.062704.34万元4.64%9300832 新产业55.57-0.232373.09万元5.75%10300642透景生命17.151.841917.71万元7.78% ...

Company Overview - Sely Medical's stock price showed volatility on August 7, closing at 27.40 yuan, down 2.32% from the previous trading day [1] - The opening price was 27.77 yuan, with a high of 29.32 yuan and a low of 27.22 yuan, resulting in an intraday fluctuation of 7.49% [1] - The company operates in the pharmaceutical commercial sector, focusing on the research, production, and sales of medical devices, including in vitro diagnostic reagents and medical equipment [1] Financial Performance - On August 7, the net outflow of main funds was 139 million yuan, accounting for 2.66% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow reached 465 million yuan, representing 8.89% of the circulating market value [1] - The trading volume for the day was 443,300 hands, with a total transaction amount of 1.247 billion yuan [1]

Core Insights - The DRG/DIP concept increased by 1.00%, ranking 10th among concept sectors, with 11 stocks rising, including Jiarun Technology which hit a 20% limit up [1] - Major gainers in the sector included Jiahe Meikang, Wanda Information, and Taiji Co., with respective increases of 3.68%, 3.08%, and 2.98% [1] - The sector experienced a net outflow of 229 million yuan, with 10 stocks seeing net inflows, and Wanda Information leading with a net inflow of 65.92 million yuan [2][3] Sector Performance - The top-performing concept sectors included Rare Earth Permanent Magnet (+3.24%), Brain-Computer Interface (+2.69%), and Hyperbaric Oxygen Chamber (+2.56%), while the weight-loss drug sector saw a decline of -1.70% [2] - The DRG/DIP concept had a net inflow ratio led by Wanda Information at 10.09%, followed by ST Yilianzhong at 5.78% and Taiji Co. at 4.82% [3][4] Stock Specifics - Key stocks in the DRG/DIP concept included: - Wanda Information: +3.08%, net inflow of 65.92 million yuan, turnover rate of 5.34% [3] - Weining Health: +1.72%, net inflow of 62.81 million yuan, turnover rate of 6.37% [3] - Taiji Co.: +2.98%, net inflow of 42.14 million yuan, turnover rate of 5.36% [3] - Notable declines were seen in stocks like Maidi Technology (-2.61%) and Seli Medical (-2.32%), with significant net outflows [4]

截至2025年8月6日收盘，塞力医疗股价报28.05元，较前一交易日下跌1.45元，跌幅4.92%。当日开盘价 为29.85元，最高触及30.29元，最低下探至27.90元，成交量为38.61万手，成交额达10.99亿元。 塞力医疗属于医药商业板块，公司主营业务涵盖医疗器械、体外诊断产品的研发、生产和销售，同时提 供医疗供应链管理服务。其业务范围涉及医院集约化运营、区域检验中心建设等领域。 8月6日早盘，塞力医疗股价快速回调，5分钟内跌幅超过2%，盘中最低报29.21元。当日主力资金净流 出1.65亿元，近五个交易日累计净流出4.02亿元。 风险提示：股市有风险，投资需谨慎。 来源:金融界 ...

Core Viewpoint - The stock price of Saily Medical closed at 29.50 yuan on August 5, showing a decline of 0.51% compared to the previous trading day, with notable price fluctuations throughout the day [1] Company Overview - Saily Medical's main business includes centralized marketing and service for medical testing, as well as the agency, research, production, and sales of in vitro diagnostic products [1] - The company holds a significant market influence in the medical commercial sector within Hubei province [1] Market Activity - On August 5, the net outflow of main funds was 4.6852 million yuan, with a cumulative net outflow of 276 million yuan over the past five trading days [1] - The trading volume for the day reached 1.055 billion yuan, with a turnover rate of 18.99%, indicating a high level of market activity [1]

证券之星消息，8月4日医药商业板块较上一交易日下跌0.23%，塞力医疗领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301015 | 目洋医药 | 22.39 | 1.91% | 12.41万 | 2.71亿 | | 603939 | 益丰药房 | 24.60 | 1.61% | 6.75万 | 1.65亿 | | 603233 | 大参林 | 17.58 | 0.92% | 4.67万 | 8141.04万 | | 600511 | 国药股份 | 30.04 | 0.74% | 5.65万 | 1.69亿 | | 603122 | 合富中国 | 7.28 | 0.55% | 6.14万 | 4434.06万 | | 301017 | 漱玉平民 | 13.35 | 0.45% | 6.99万 | 9203.55万 | | 605266 | 健之佳 | 22.0 ...

创新药概念股集体走低，奥翔药业（603229）触及跌停，科兴制药跌超10%，塞力医疗（603716）、德 展健康（000813）、海创药业跌幅居前。 ...

Group 1 - The medical waste treatment sector saw an increase of 1.24% as of the market close on August 1, with a total capital inflow of 15.67 million [1] - A total of 25 stocks in the sector experienced gains, while 4 stocks declined [1] - The top-performing stocks included: Saili Medical (6.2%), Zhongshan Public Utilities (4.26%), Xuelang Environment (4.02%), Donghua Technology (4.0%), and Gangtong Medical (3.41%) [1] Group 2 - The stocks with the largest capital inflow were: Saili Medical with 3.49 million, Zhongshan Public Utilities with 6.48 million, and Xuelang Environment with 4.99 million [1] - The stocks that experienced the largest declines included Huakang Clean (−5.97%), Wanbangda (−0.64%), and Zhonggang International (−0.47%) [1] - The overall market sentiment in the medical waste treatment sector appears positive, with significant capital inflow into several key stocks [1]

Market Performance - As of August 1, the DRG/DIP concept increased by 1.87%, ranking second among concept sectors, with 19 stocks rising, including Saily Medical, Sichuang Medical, and Jiayuan Technology, which rose by 6.20%, 5.04%, and 5.00% respectively [1] - The top-performing concept sectors included Animal Vaccines at 2.22% and BC Batteries at 1.71%, while the worst performers included the China Shipbuilding System at -2.54% and Military Equipment Restructuring at -1.90% [2] Capital Flow - The DRG/DIP concept sector saw a net inflow of 109 million yuan, with 14 stocks receiving net inflows, and 10 stocks exceeding 10 million yuan in net inflow, led by Weining Health with a net inflow of 93.03 million yuan [2] - Other notable net inflows included Saily Medical at 33.50 million yuan, Rongke Technology at 31.92 million yuan, and Sichuang Medical at 30.87 million yuan [2] Stock Performance - The top stocks in the DRG/DIP concept based on net capital inflow included Weining Health with a 3.31% increase and a turnover rate of 9.45%, followed by Saily Medical at 6.20% and a turnover rate of 25.56% [3] - Other significant performers included Rongke Technology at 2.31% and Sichuang Medical at 5.04%, with respective net inflow ratios of 6.05% and 5.47% [3][4]